By George Omagbemi Sylvester
Nigeria has received its first shipment of the long-acting HIV prevention injection known as Lenacapavir, marking a significant step in expanding the country’s arsenal against new HIV infections. The development was announced on Thursday, March 12, 2026, by the National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) under the Federal Ministry of Health and Social Welfare.
According to the ministry, the injectable drug arrived in Nigeria on Tuesday, March 10, 2026, and will be deployed as pre-exposure prophylaxis (PrEP) — a preventive treatment for people who are HIV-negative but at risk of infection.
Unlike traditional HIV prevention medication that requires daily oral pills, Lenacapavir is administered only twice a year, a feature health experts say could improve adherence and expand access to prevention services among vulnerable populations who struggle with daily medication.
The introduction of the drug, approved by Coordinating Minister of Health and Social Welfare Muhammad Ali Pate and supported by the Global Fund, represents a major milestone in Nigeria’s efforts to curb HIV transmission and strengthen public health responses nationwide.
Officials say preparations are already underway to integrate the new injection into Nigeria’s national HIV prevention programme as part of broader efforts to end the epidemic.
Leave a Reply